Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome

Abstract

Although the expansion of myeloid-derived suppressor cells (MDSCs) has been reported in autoimmune disorders, it is largely unclear how MDSCs contribute to the development of primary Sjögren syndrome (pSS). In this study, we found significantly increased MDSCs with gradually diminished suppressive capacity during disease development in mice with experimental Sjögren syndrome (ESS). The ligand for glucocorticoid-induced TNFR family-related protein (GITRL) was increased along ESS progression, whereas the increased GITRL was found to attenuate the immunosuppressive function of MDSCs. Moreover, blocking GITR signal in MDSCs significantly restored their immunosuppressive function and alleviated ESS progression in mice. In pSS patients, expanded MDSCs were found to express low levels of arginase. Significantly increased serum GITRL levels were closely correlated with patients with higher Sjögren syndrome disease activity index. Furthermore, treatment with recombinant GITRL markedly reduced the immunosuppressive function of human MDSCs. Together, our studies have demonstrated a critical role of GITRL in modulating the suppressive function of MDSCs, which may facilitate the validation of GITRL as a therapeutic target for the treatment of pSS.

Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9

“…[47,48] The immunosuppression of splenic G-MDSCs was detected by a T cell proliferation assay. [47,48] The immunosuppression of splenic G-MDSCs was detected by a T cell proliferation assay.…”

Exosome derived from CD137‐modified endothelial cells regulates the Th17 responses in atherosclerosis

“…Splenic CD4 + T cells were isolated from wild‐type mice (6‐8 weeks old) using CD4 + T‐cell microbeads (Miltenyi Biotec). For Th17 cell differentiation, CD4 + T cells were cultured for 72 hours in the presence of anti‐CD28 mAb (2 μg/mL), IL‐6 (30 ng/mL), TGF‐β(5 ng/mL), anti‐IFN‐γmAb (5 μg/mL), anti‐IL‐4 mAb (5 μg/mL) and IL‐23 (30 ng/mL) in a 24‐well plate pre‐coated with anti‐CD3 mAb (2 μg/mL).…”

CD4+ T Cell‐Released Extracellular Vesicles Potentiate the Efficacy of the HBsAg Vaccine by Enhancing B Cell Responses

“…[54] For staining of total CD40L in EL-4 cells, single-cell suspensions were first stained with fluorescent conjugated anti-CD40L mAb, then fixed, permeabilized, and stained with fluorescent conjugated anti-CD40L mAb again according to the intracellular staining kit instructions. For intracellular staining of Th1 and Th2, single-cell suspensions were first stimulated with 50 ng mL −1 phorbol myristate acetate), 1 µg mL −1 ionomycin, and 2 µg mL −1 monensin.…”